J. B. Chemicals & Pharmaceuticals has informed that it enclosed newspaper advertisement published in Business Standard (English) and Sakal (Marathi) edition of July 3, 2024 with regard to convening of ensuing annual general meeting (AGM) of the Company on August 21, 2024 through Video Conferencing (VC)/Other Audio Video Means (OAVM). This public notice in the newspapers has been issued before dispatch of notice of the said AGM and annual report for 2023-24 to the Company's shareholders in accordance with General Circular No. 9/2023 dated September 25, 2023, read with General Circular No. 20/2020 dated May 5, 2020, General Circular No. 14/2020 dated April 8, 2020 and General Circular No.17/2020 dated April 13, 2020 issued by the Ministry of Corporate Affairs.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: